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Abstract
Introduction: Serum hyaluronic acid (sHA) is a serum biomarker for knee osteoarthritis (OA). Although sHA
concentration is elevated in patients with knee OA, the relationship between serum concentration and disease
progression remains unclear. We examined the relationship between sHA concentration and radiographic
progression of knee OA in a cohort of individuals followed for 5 years.
Methods: We prospectively enrolled 444 individuals and measured their sHA concentrations at baseline.
Anterior-posterior weight bearing knee radiographs were obtained at baseline and the 5-year endpoint.
Osteoarthritic knee changes were classified according to Kellgren–Lawrence (KL) grade, and joint space
narrowing (JSN) was measured using a Knee Osteoarthritis Computer-Aided Diagnosis (KOACAD) system. Correlations
between sHA concentration, progression in KL grade, and JSN were assessed using regression models, taking into
account potentially confounding factors.
Results: OA progressed from KL grades 0 or 1 in 129 of the 323 knees, and from KL grades 2 or 3 in 61 of the 119
knees. Higher sHA concentrations were correlated with KL grade progression (p = 0.004). The mean JSN, as assessed by
KOACAD over 5 years, was 0.23 ± 0.55 mm, and sHA concentration was positively correlated with progression of JSN in
KL grades 0 or 1 (p = 0.021) and KL grades 2 or 3 (p = 0.008) knees.
Conclusion: Serum HA concentration was positively correlated with progression of KL grade. sHA was also positively
correlated with progression of JSN in knees with and without OA, suggesting that sHA concentration may be a useful
predictor of knee OA progression.
Introduction
Osteoarthritis (OA) is a common cause of pain and dis-
ability in elderly people [1]. The prevalence of radio-
graphic knee OA among adults over 40 years old in
Japan was recently reported as up to 42.0 % in men and
62.4 % in women [2]. Knee OA imposes a heavy burden
of pain and disability, including high costs of treat-
ments, decreased productivity, and absence from work.
Consequently, although OA should be diagnosed as
soon as possible to begin treatment, the current diag-
nostic tools are inadequate. The gold standard method
of diagnosis has long been plain radiography, but the
sensitivity and specificity of that technique have been
questioned [3]. Magnetic resonance imaging (MRI) may
allow for earlier OA diagnosis because it is capable of
detecting cartilage damage, small osteophytes, subchon-
dral bone changes, and synovitis in the presence or ab-
sence of symptoms [4–6]. Nevertheless, MRI is expensive,
time consuming, and contraindicated in some patients.
Serum biomarkers are a potentially useful alternative
tool besides conventional diagnostic imaging examination.
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Biomarkers allow disease activity to be objectively evalu-
ated, are easily measured in office-based practices, and, in
rheumatoid arthritis and osteoporosis, can help patients
understand their condition. Several biomarkers are known
to be correlated with the extent of OA on radiography of
the knee and have thus been proposed as diagnostic tools
[7–10]. Among such biomarkers, serum hyaluronic acid
(sHA) is particularly promising. Several previous cross-
sectional studies have reported that measuring sHA con-
centration may be useful for not only diagnosing knee
OA, but also identifying disease duration, severity, and the
extent of OA-related knee pain [11–15]. Nonetheless, the
currently used biomarkers remain insufficiently discrimin-
ating for predicting the prognosis of OA [7]. The concen-
tration of sHA is thought to reflect the extent of synovitis,
which is present at the onset of OA and accelerates dis-
ease progression by producing proteases and cytokines
[16–18]. Therefore, sHA may have potential as a prognos-
tic indicator of progressive knee OA, but the relationship
between sHA and knee OA has only been examined in a
few longitudinal studies [19, 20].
In the present study, we determined the relationship
between sHA concentration and radiographic changes in
the knee in a 5-year prospective patient cohort. To ob-
jectively assess knee radiography, the knee osteoarthritis
computer-aided diagnosis (KOACAD) system was used
to measure joint space narrowing (JSN) and osteophyte
formation, and the knees were grouped according to the
Kellgren–Lawrence (KL) grade [21, 22]. We hypothe-
sized that sHA concentration is correlated with the se-
verity of knee OA and can predict the development and
progression of OA as seen on radiography of the knee.
Methods
Participants
The participants had volunteered for the Iwaki Health
Promotion Project, which is a community-based pre-
ventative medicine program that aims to improve
average life expectancy by performing general health
checkups and prophylactic interventions, as previously
described [12, 13]. All participants gave their written in-
formed consent, and the study was conducted with the ap-
proval of the ethics committee of the Hirosaki University
School of Medicine.
A total of 866 volunteers (325 men and 561 women)
from approximately 12,000 eligible residents enrolled in
the project in 2008 (Fig. 1). The participants were
recruited using mass media advertisements and public
health nurses. Of these, 70 declined radiographic exam-
ination, and 96 were excluded because of a history of
total knee arthroplasty, rheumatoid arthritis, renal fail-
ure, liver failure, malignant tumors, or having returned
incomplete questionnaires. After 5 years, 450 of the par-
ticipants underwent the endpoint checkup (follow-up
rate 62.5 %): of these, 6 (1.3 %) had undergone total knee
arthroplasty. In total, 444 participants (158 men and 286
women) were included in the analysis. The 270 par-
ticipants who dropped out over the 5 years led to a low
follow-up rate. However, because participation in this
observational cohort was part of a general health check-
up and entirely voluntary, we could not force them to
participate in the endpoint checkup. However, no signifi-
cant differences were found in the baseline data between
the followed participants and those who dropped out
(Table 1). Additional questionnaires on lifestyle habits
Fig. 1 Number of participants in the cohort enrolled, excluded, and followed up at 5 years. The values in parentheses indicate the number
excluded. RA rheumatoid arthritis, TKA total knee arthroplasty
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were administered, including questions about alcohol
consumption, cigarette smoking, and fitness habits. The
presence of these habits was defined as drinking, smok-
ing, or taking exercise one or more days per week. These
habits were included in the statistical analysis as a
categorical variable (yes/no). Height and weight were
measured and recorded by project team staff, and body
mass index (BMI) was calculated.
Serum HA assay
Fasting venous blood specimens were taken from all par-
ticipants at baseline in the early morning for biochemical
examination. Serum was obtained by centrifugation,
separated into 0.7 ml aliquots, and stored at −80 °C for
later analysis. The sHA concentration was determined
using the Hyaluronan Assay Kit (Seikagaku Corporation,
Tokyo, Japan). The intra-assay and inter-assay coeffi-
cients of variation were 3.2 % and 5.0 %, respectively,
when a pooled sample of normal human sera was tested.
Radiographic examination of the knee
Experienced radiologic technicians took the weight-
bearing and anterior-posterior radiographs of both knees
with foot map positioning, at baseline and at the end-
point. The beam was positioned parallel to the floor with
no angle and aimed at the joint space, following Oka’s
technique for using the KOACAD system (INOTECH
corporation, Hiroshima, Japan) [21]. The images were
converted into Joint Photographic Experts Group (JPEG)
format files. The severity of OA in each knee was classi-
fied by two trained orthopedic surgeons (YI and RI) as
KL grade 0 to 4 using the KL radiographic atlas [22].
The interclass correlation coefficient between the two
surgeons was 0.815. The surgeons were blinded to the
sequence in which the radiographs were acquired and
the clinical status of the participants. A diagnosis of knee
OA was made in participants with KL grades of 2, 3 or 4
in the most affected knee, and the same knee was exam-
ined at the endpoint. Development of knee OA was de-
fined as knees with KL grades 0 or 1 at baseline
changing to KL grades 2, 3, or 4 over the 5 years. Pro-
gression of knee OA was defined as knees with KL grade
2 changing to KL grade 3 or 4, and as knees with KL
grade 3 changing to KL grade 4, over 5 years. The joint
space width (JSW) at the narrowest point in the medial
or lateral compartment of the femoro-tibial joints and
the total osteophyte areas on the proximal tibia and dis-
tal femur were calculated from calibrated radiographs
using the KOACAD system. Joint space narrowing (JSN)
was defined as a reduction in the JSW over 5 years. The
rate of JSN and changes in osteophyte formation from
baseline to the 5-year endpoint were calculated. The
KOACAD system is a fully automated system for
quantifying the major features of knee OA on standard
radiographs, allowing for an objective, accurate, and
straightforward assessment of the structural severity of
knee OA in general clinical practice. It has proven to be
highly reliable and reproducible, with an intraclass cor-
relation coefficient of 1.00 based on the validation study
that included 1,979 knee radiographs [21]. After defining
a region of interest (ROI) in the KOACAD system that
included the tibiofemoral joint space, a vertical neigh-
borhood difference filter was applied to identify loca-
tions with high absolute values of difference of scales.
Within the ROI, the outline of the femoral condyle was
defined as the upper rim of the joint space. The outlines
of the anterior and posterior margins of the tibial plat-
eau were similarly drawn, and the middle line between
the two outlines was defined as the lower rim of the
joint space. The minimum JSW was further determined
as the minimum vertical distance in the joint space area.
To measure osteophyte area, the medial outlines of the
tibia and femur from the inflection point were extended
upward to the joint level and the area that became
medially prominent over the smoothly extended outline
was designated as the osteophyte area [21].
Statistical analysis
The Mann–Whitney U test and Chi square test were
used to compare the demographic data between the
participants who were followed and those who dropped
out. The Kolmogorov–Smirnov test was used to verify
that the sHA concentration and rate of JSN data were
normally distributed, which they were (p = 0.200).
Spearman’s correlation coefficient was calculated to
Table 1 Baseline demographic data and Kellgren − Lawrence
(KL) grades of the participants who were followed up and those
who dropped out
Dropped out (n = 270) Followed up (n = 444)
Age, years 56.9 ± 14.4 55.4 ± 12.0*
Female, % 61.4 64.4
Body mass index, kg/m2 22.9 ± 3.2 23.0 ± 3.1
Serum HA, ng/ml 67.2 ± 48.2 64.7 ± 46.2
Smoking habit, % 18.3 17.5
Drinking habit, % 41.1 42.6
Fitness habits, % 22.3 31.6
KL grade 0/1, n 177 323
KL grade 2, n 67 91
KL grade 3, n 22 28
KL grade 4, n 4 2
The values are baseline demographic data for the participants who dropped
out and those who were followed up. Patients who underwent total knee
arthroplasty during the 5 years are not included in this table. *P value <0.05
(considered statistically significant) for comparison of the two groups HA
hyaluronic acid
Data were mean ± SD
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examine the association between sHA concentration,
rate of JSN, and risk factors for OA based on age, sex,
and BMI. The parameters determined from the knee
radiographs (JSW, JSN, rate of JSN, osteophyte area, and
osteophyte formation for each KL grade) were compared
using analysis of variance (ANOVA). The relationship
between sHA and radiographic change in the knee was
investigated using cross-sectional analysis at baseline
and longitudinal analysis over 5 years. For the cross-
sectional analysis, the mean sHA concentrations were
compared using ANOVA and Tukey’s post hoc test.
Logistic regression analysis was performed using pro-
gression from KL grades 0 or 1 and progression from
KL grades 2 or 3 as dependent variables and age (per year
of age), sex (female versus male), BMI (per 1 kg/m2), and
sHA concentration (per 1 ng/ml) as independent vari-
ables, which were adjusted for cigarette smoking, alcohol
consumption, and fitness habits. Similarly, linear regres-
sion analysis was performed using rate of JSN or osteo-
phyte formation as the dependent variable and age, sex,
and BMI as the independent variables, which were
adjusted for cigarette smoking, alcohol consumption, and
fitness habits. Finally, to estimate the predictive cutoff
level of sHA concentration for developing knee OA from
KL grades 0 or 1 and the progression of knee OA from
KL grades 2 or 3, receiver operating characteristic (ROC)
analysis was performed. The values of sHA were used as a
single variable in this analysis. The false positive fraction
was plotted against the 1 − true positive fraction, and the
cutoff point was defined as the point of the maximum
slope, i.e. the nearest point to true positive. Furthermore,
the area under the curve (AUC) was calculated to evaluate
the validity of the ROC analysis. Data input and analyses
were performed in SPSS version 12.0 J (SPSS Inc.,
Chicago, IL, USA). P values <0.05 were considered statisti-
cally significant.
Results
The mean age of the followed participants at baseline was
55.4 ± 12.0 years (range 25–85 years), which was lower than
that of the participants who dropped out (p = 0.04). The
mean BMI was 23.0 ± 3.1 kg/m2 (range 15.6–37.5 kg/m2).
Women accounted for 64.4 % of the subjects. No
significant differences were found for gender (p = 0.76),
BMI (p = 0.97), sHA concentration (p = 0.35), KL grade
(p = 0.13), or lifestyle habits between the followed subjects
and those who dropped out (Table 1).
Serum HA concentration and cross-sectional analysis
The mean baseline sHA concentration of the partici-
pants who were followed up was 64.7 ± 46.2 ng/ml
(range 25.0 − 304.0 ng/ml), which was not significantly
different to the concentration in those who dropped out
(p = 0.353). The serum HA concentration increased with
age (correlation coefficient 0.67, p <0.001) and BMI
(correlation coefficient 0.15, p = 0.006), but sHA concen-
tration was not correlated with sex (correlation coeffi-
cient 0.03, p = 0.595). Cross-sectional analysis showed
that the mean sHA concentration increased with the se-
verity of knee OA, and significant differences were found
between all of the KL grades, except between KL grades
0 and 1 (Fig. 2).
Radiographic evaluation of knee OA
There were 323 participants with KL grade 0 or 1, 91
with grade 2, 28 with grade 3, and 2 with grade 4
(Table 2). Radiographic examination at the 5-year end-
point showed that the KL grade in 190 of 443 partici-
pants (42.1 %) with KL grades 0, 1, 2, or 3 at baseline
had progressed. Osteoarthritic disease was assessed as
having developed in 14 knees and progressed in 61
knees.
The KOACAD parameters were determined among
all participants and by KL grade. The mean JSW was
3.46 ± 0.82 mm among all participants, and for KL
grades 0 through 4 it was 3.9 ± 0.6, 3.5 ± 0.7, 3.2 ± 0.7,
2.5 ± 1.2, and 0.2 ± 0.1 mm, respectively. The mean
progression of JSN over 5 years was 0.23 ± 0.55 mm
among all participants, and for KL grades 0 through 4 it
was 0.2 ± 0.5, 0.1 ± 0.5, 0.3 ± 0.5, 1.0 ± 0.8, and 0 mm, re-
spectively. The mean rate of JSN was 9.31 ± 17.6 % (−18.2
to 100.0 %) among all participants, and for KL grades 0
through 4 it was 3.3, 2.0, 9.4, 50.0, and 0 %, respectively.
The mean osteophyte area was 2.05 ± 8.74 mm2
among all participants, and for KL grades 0 through
4 it was 1.0 ± 6.7, 1.3 ± 4.7, 1.8 ± 4.5, 12.1 ± 26, and
15.7 ± 22 mm2, respectively. The mean osteophyte for-
mation was 1.62 ± 12.89 mm2 among all participants,
and for KL grades 0 through 4 it was 0.6, 0.5, 3.6,
6.6, and 12.6 mm2, respectively.
Fig. 2 Concentration of serum hyaluronic acid by Kellgren–Lawrence
(KL) grade. P values <0.05 were found compared with *KL grade 0,
†grade 1, ‡grade 2, and #grade 3
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Longitudinal analysis
The Spearman’s coefficient for correlation between sHA
concentration and the rate of JSN was 0.404 (p <0.001)
(Fig. 3). Adjusted logistic regression analysis showed that
higher sHA concentration was correlated with progres-
sion from KL grades 2 or 3 (p = 0.004), but not with de-
velopment from KL grades 0 or 1 (p = 0.196; Table 3). A
positive correlation was found between being female and
the development of OA from KL grades 0 or 1, and
aging and higher BMI were correlated with both the de-
velopment and progression of OA. However, significant
correlation was found between higher sHA concentra-
tion and the progression of JSN in knees with KL grades
0 or 1 at baseline (p = 0.021) and with KL grades 2 or 3
at baseline (p = 0.008; Table 4). ROC analysis showed
that the sHA cutoff value for predicting the development
from KL grades 0 or 1 was 35.1 ng/ml (AUC 0.603), and
the odds ratio at that point was 2.19 (Fig. 4). The sHA
cutoff value for predicting the progression from KL
grades 2 or 3 was 51.9 ng/ml (AUC 0.707), and the odds
ratio at that point was 4.89 (Fig. 5).
Discussion
The results of the present longitudinal study show that
sHA concentration at baseline was positively correlated
with the development or progression of KL grade. Fur-
thermore, sHA concentration at baseline was correlated
with JSN in both normal and severely osteoarthritic
knees, as assessed by radiograph. These findings are
clinically relevant and suggest that sHA concentration
reflects not only the severity, but also the likelihood of
progression of knee OA. Thus, sHA concentration may
be useful as a prognostic marker for predicting JSN,
though not for predicting osteophyte formation. Because
OA is a long-term, chronic disease, it is difficult to fully
understand the relationship between sHA and the inci-
dence of OA based on only a 5-year observation. How-
ever, the present study is the first report showing that an
sHA cutoff value of 51.9 ng/ml was predictive of OA
progression based on ROC analysis. Concentrations of
sHA >51.9 ng/ml indicate a high risk of progression of
knee OA. We hope that these results are applied to the
screening during conventional knee examinations or the
clinical risk evaluation for progressive OA after knee
injury or surgery. Further clinical studies are needed to
determine whether sHA can predict the incidence of
OA, which was not determined in the present study.
The long-term cohort with a large sample size used in
the present study made it possible to estimate the sHA
cutoff value as 51.9 ng/ml, which was indicative of a
five-fold increase in the risk of JSN over 5 years. Several
studies have reported sHA concentration cutoff values
as biomarkers for knee OA. For example, Kaneko et al.
suggested cutoff values of sHA to define the presence of
knee OA using confidence intervals matched with the
KL grades in a clinical cross-sectional study [23]. How-
ever, the present study is the first to estimate the cutoff
value predictive of the progression of knee OA based on
a longitudinal cohort. Unfortunately, the reliability of the
cutoff value for the development of knee OA was low
because the AUC was 0.603. On the other hand, the cut-
off value of the progression of OA in those with moder-
ate knee OA was valid and reliable based on its higher
AUC. Thus, we believe that this cutoff value should be
useful during screening for abnormal knee conditions or
as an additional evaluation for the risk of OA pro-
gression when used in combination with conventional
imaging tools.
The mechanisms underpinning the phenomenon of
elevated sHA concentration in progressive knee OA are
thought to be mechanical stress and synovitis with cartil-
age degeneration [24]. OA is characterized by focal dam-
age to the articular cartilage centered on the load-bearing
areas, osteophyte formation at the joint margins, subchon-
dral bone changes, and synovitis [17]. Synovitis is present
at the onset of OA [18] and results in the production of
Table 2 Knee osteoarthritis in participants by Kellgren–Lawrence
(KL) grade at baseline, and changes over 5 years
Baseline Endpoint Development/
progressionKL grade Number KL grade
0/1 2 3 4
0, 1 323 194 96 33 129
2 91 44 43 4 47
3 28 14 14 14
4 2 2
Total 444 194 140 90 20 190
The values are the numbers of participants
Fig. 3 Serum hyaluronic acid concentration versus the rate of joint
space narrowing
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hyaluronic acid (HA) and pro-inflammatory cytokines
[25]. In addition, synovitis activates fibroblasts, which pro-
mote the production of other pro-inflammatory cytokines
such as tumor necrosis factor-α and interleukin-1β [17].
These cytokines promote matrix metalloproteinase pro-
duction by fibroblasts, which degrade the articular
cartilage matrix [16]. Thus, the presence of synovitis is
thought to contribute to the progression of knee OA.
Ayral et al. suggested that synovitis was also predictive of
subsequent chondropathy [26]. Severe OA is a risk factor
for acceleration of the progression of knee OA [26], which
broadly reflects our findings that sHA concentration was
correlated with disease progression in the longitudinal and
cross-sectional analyses.
Although previous studies have described the relation-
ship between sHA and progression of knee OA, the data
were limited. Pavelka et al. reported that the non-
adjusted correlation coefficient between sHA and JSN
over 2 years was 0.56 based on 89 patients with knee
OA [19]. Similarly, Sharif et al. reported that the sHA
concentration measured in 12 patients with 2 mm JSN
over 5 years was higher than that in patients without
progressive JSN [20]. However, these studies had rela-
tively small sample sizes, selection biases derived from
focusing only on patients with knee OA, and used only
JSN as the sole outcome measure; therefore the relation-
ship between sHA and the pathogenesis of OA was not
fully examined. In contrast, we elucidated these relation-
ships in a general population of individuals with normal
knees and with early and severe knee OA, providing data
that have not been previously reported. The 5-year
follow-up period also allowed us to determine the rela-
tionship between sHA and JSN, although no significant
correlation with osteophyte development was found.
This suggests that sHA concentration is a useful screen-
ing tool for detecting patients at risk of progressive JSN,
even in individuals with normal or early OA of the knee.
The sHA concentration is reported to be a specific
biomarker for OA of other major joints, besides the
knee, and the lumbar spine [13], but sHA concentration
increases with age because of an impaired ability to
metabolize HA in the elderly [27]. HA is actively se-
creted into joint fluid by the surrounding synovial lining
cells [28]. When intra-articular fluid pressure is in-
creased, HA is also distributed to the liver (90 %), kidney
(9 %), and spleen (1 %) via the lymphatic and capillary
systems [27]. The increase in sHA concentration with age
may even be a consequence of progressive age-related
hepatic and renal impairment [29]. sHA concentration is
Table 3 Relationship between serum hyaluronic acid concentration and changes in Kellgren–Lawrence (KL) grade
Development from KL grade 0/1 Progression from KL grade 2/3
β P value Odds 95 % CI β P value Odds 95 % CI
Females 0.87 0.005 2.39 1.27−4.24 0.54 0.472 1.71 0.40–7.42
Age 0.04 0.014 1.04 1.01–1.07 0.07 0.016 1.08 1.01–1.14
BMI 0.16 0.001 1.18 1.07–1.30 0.24 <0.001 1.28 1.11–1.46
sHA 0.01 0.196 1.01 0.99–1.02 0.02 0.004 1.02 1.01–1.03
Logistic regression analysis of KL grades 0 or 1 and KL grades 2 or 3 at baseline. Dependent variables: development from KL grades 0 or 1 and progression from
KL grades 2 or 3. Independent variables: age, sex, body mass index (BMI), and serum hyaluronic acid (sHA) concentration, which was adjusted for lifestyle
parameters. KL grade β standardized coefficient
Table 4 Correlations between baseline serum hyaluronic acid
concentrations and the KOACAD parameters from knee
radiographs
KL grade 0/1 KL grade 2/3
β P value β P value
Rate of joint space narrowing 0.15 0.021 0.24 0.008
Osteophyte formation −0.05 0.422 0.25 0.017
Linear regression analysis was performed on knees with radiographic
Kellgren–Lawrence (KL) grades 0 or 1 and KL grades 2 or 3 at baseline.
Dependent variables: rate of joint space narrowing and osteophyte formation
in KL grades 0 or 1 and KL grades 2 or 3. Independent variables: age, sex,
body mass index, and serum hyaluronic acid (sHA) concentration, which was
adjusted for lifestyle parameters. The values indicate the correlation with
sHA concentration. KOACAD knee osteoarthritis computer-aided diagnosis,
β standardized coefficient
Fig. 4 Receiver operating characteristic (ROC) curves for serum
hyaluronic acid (sHA) and development of knee osteoarthritis from
Kellgren−Lawrence (KL) grades 0 or 1. AUC area under curve, Odds
odds ratio
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reported to be influenced by other factors, including renal
failure [30], liver failure [31], rheumatoid arthritis [32],
malignancy [33], and physical activity [34]. We were able
to adjust for these potentially confounding factors, allow-
ing us to more accurately determine the relationship be-
tween sHA concentration and knee OA.
Changes in the femoro-tibial JSW are recommended
as the primary assessment of joint damage in knee OA
[35]. The results of studies that have sought to quantify
the annual progression of JSN are affected by the popu-
lation studied. Mazzuca et al. reported that the mean
annual JSN ranged from 0.06 to 0.6 mm per year [36],
and Pavelka et al. reported that JSN progressed by
0.4 mm over 2 years in patients diagnosed with knee OA
[19]. The annual increase in the incidence of osteophyte
formation or JSN in middle-aged subjects with radio-
graphically identified KL grades 0 or 1 OA of the knee is
reported to be 4 % [37]. Our present findings, based on
a relatively unselected cohort, are in broad agreement
with these studies.
We used the KOACAD system to measure JSW. The
use of this validated technique permitted an objective
analysis of an important outcome measure and removed
the possibility of bias. JSW is correlated with cartilage
volume in the medial femoro-tibial compartments [38],
and progression of radiographic JSN appears to be pre-
dictive of cartilage loss as assessed with MRI [39].
Nevertheless, JSN should be evaluated very carefully on
radiographs because it is affected by meniscal malposi-
tion and degeneration as well as cartilage defects [40].
Distinguishing between cartilage defects with meniscal
tears and dislocation in those with painful early OA is
important [41]. Six of our 450 participants (1.3 %)
underwent total knee arthroplasty during the study
period, broadly comparable with the findings of a cohort
study conducted by Muraki et al., in which 30 people
(1.0 %) in a population of 2,992 underwent knee arthro-
plasty during a 3.3-year surveillance period [42].
The present study has several limitations. First, we did
not evaluate the development or progression of OA in
other joints besides the knee, and the presence of gener-
alized OA is reported to be associated with the progres-
sion of knee OA [43]. Furthermore, patients who have
generalized OA at multiple sites, including the hands
[44] and hip [11], also have higher sHA concentrations.
Nonetheless, OA of the knee appears to have the great-
est influence on sHA concentration. Inoue et al. found
that the correlation between sHA concentration and OA
was greatest in those with knee OA (r = 0.395), com-
pared with OA of the hip (r = 0.108), or wrist and hand
(r = 0.262) [12]. Although it would have been better to
account for generalized OA in the sHA concentration,
we could not examine radiographs of all the joints in
each patient for this study. Second, the follow-up rate at
Fig. 5 Receiver operating characteristic (ROC) curves for serum hyaluronic acid (sHA) and progression of knee osteoarthritis from KL grades 2 or 3.
AUC area under curve, Odds odds ratio
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the 5-year endpoint was only moderate because of a loss
of participants. This presents a potential risk of selection
bias. The sample number of the cohort was determined
by the voluntary participation of community residents
because this checkup was performed as part of an
annual general health checkup; we could not control the
follow-up rate. A large sample number is important for
accurate statistics, and a high follow-up rate is also im-
portant for maintaining the characteristics of the sub-
jects at baseline. We believe that the effect on the results
of the patients dropping out was minimal because the
characteristics of the followed subjects and those who
dropped out were very similar. Third, there was a statis-
tical limitation. The relationship between sHA and the
progression of OA was assessed using two tests, linear
regression analysis and logistic regression analysis. The
concentration of sHA was a continuous parameter,
which made it difficult to evaluate the outcomes using
logistic regression analysis. Although it would have been
better to use cutoff values or 10-unit shifts for this
analysis, we did not want to statistically overestimate.
Further, we could not use such methods because we
found no past literature describing the creation of
categories or use of such sHA scales that were based
purely on evidence. Still, we found a significant correl-
ation between sHA and progression of OA using logistic
regression analysis, and the confidence interval was very
tight. Although this was a limitation, the aims of the
present study were to determine the relationship be-
tween sHA concentration and longitudinal changes in
radiographic OA and the utility of using sHA to predict
JSN, which were appropriately tested using linear regres-
sion analysis. Fourth, it was difficult to analyze the cutoff
value for the development of OA with this study design.
The cutoff values were 35.1 ng/ml for the development
of OA, and 59.1 ng/ml for progression of OA. To better
determine the cutoff value for the development of OA,
subjects from a wider range of ages would be needed.
Here, the patients were limited to middle-aged women
and included many young patients at very low risk of de-
veloping OA. Furthermore, we discussed above why
sHA concentration may vary with the severity of OA.
The presence of OA is a risk factor for the acceleration of
progressive OA. We believe that this point is one reason
why the predictive value of sHA for progression was
higher than that for OA development. Fifth, we were only
able to measure sHA concentration, even though other
biomarkers have been reported to be useful [45, 46].
Ishijima et al. reported that the serum concentrations of
cartilage type II collagen cleaved by collagenase and
cartilage type II procollagen carboxy propeptide, and
the urinary concentration of cartilage type II collagen
C-telopeptide, are elevated in patients with knee pain,
in addition to the sHA concentration [14]. Although sHA
is reported to have better predictive value for knee OA
[7], the etiology of disease development and progression
may vary between individuals and populations. The rela-
tionships between potential biomarkers and whether they
complement each other warrant further study [47]. Sixth,
the best method for measuring JSW using radiography re-
mains controversial, and radiography-based values are
typically less than those measured using MRI. In the
present study, to achieve a more objective evaluation, each
parameter was measured using the KOACAD system. Al-
though the range of standard deviations was slightly wider
than ideal, these results were similar to those measured by
Oka et al., who reported mean JSWs of 3.22 ± 0.96 mm in
male subjects and 2.65 ± 0.95 in female subjects based on
5,950 knee radiographs [48].
Despite these limitations, the results of this study based
on a general population clearly show that sHA concentra-
tion is strongly associated with the severity of knee OA,
progression of the disease, and the extent of knee symp-
toms. This longitudinal follow-up study elucidated the re-
lationship between sHA concentration and radiographic
changes in the knee over 5 years. sHA appears to be a
valuable biomarker for knee OA and has utility as part of
routine clinical evaluation to allow for early detection and
intervention to prevent the progression of knee OA.
Conclusions
The concentration of sHA was positively correlated with
the severity of radiographic knee OA. Furthermore, over
5 years, higher sHA concentrations were positively corre-
lated with the progression of KL grade in those with knee
OA and of JSN in those both with and without knee OA.
The cutoff values of sHA concentration predictive of the
development and progression of OA were estimated.
These results suggest that elevated sHA concentration can
be used as a predictor of knee OA progression.
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